• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病与 Tau 自组装:寻找缺失的环节。

Alzheimer's Disease and Tau Self-Assembly: In the Search of the Missing Link.

机构信息

Laboratory of Neurosciences and Functional Medicine, International Center for Biomedicine (ICC) and Faculty of Sciences, University of Chile, Santiago 7800020, Chile.

Indian Scientific Education and Technology Foundation, Lucknow 226002, India.

出版信息

Int J Mol Sci. 2022 Apr 10;23(8):4192. doi: 10.3390/ijms23084192.

DOI:10.3390/ijms23084192
PMID:35457009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9032712/
Abstract

Alzheimer's disease (AD) is a multifactorial neurodegenerative disease characterized by progressive cognitive impairment, apathy, and neuropsychiatric disorders. Two main pathological hallmarks have been described: neurofibrillary tangles, consisting of tau oligomers (hyperphosphorylated tau) and Aβ plaques. The influence of protein kinases and phosphatases on the hyperphosphorylation of tau is already known. Hyperphosphorylated tau undergoes conformational changes that promote its self-assembly. However, the process involving these mechanisms is yet to be elucidated. In vitro recombinant tau can be aggregated by the action of polyanions, such as heparin, arachidonic acid, and more recently, the action of polyphosphates. However, how that process occurs in vivo is yet to be understood. In this review, searching the most accurate and updated literature on the matter, we focus on the precise molecular events linking tau modifications, its misfolding and the initiation of its pathological self-assembly. Among these, we can identify challenges regarding tau phosphorylation, the link between tau heteroarylations and the onset of its self-assembly, as well as the possible metabolic pathways involving natural polyphosphates, that may play a role in tau self-assembly.

摘要

阿尔茨海默病(AD)是一种多因素神经退行性疾病,其特征是进行性认知障碍、冷漠和神经精神障碍。已经描述了两种主要的病理特征:神经原纤维缠结,由 tau 寡聚物(过度磷酸化的 tau)和 Aβ斑块组成。蛋白激酶和磷酸酶对 tau 的过度磷酸化的影响已经为人所知。过度磷酸化的 tau 会发生构象变化,从而促进其自组装。然而,涉及这些机制的过程尚待阐明。体外重组 tau 可以通过多阴离子(如肝素、花生四烯酸,以及最近多磷酸盐)的作用聚集。然而,体内发生这种过程的方式尚不清楚。在这篇综述中,我们通过搜索该领域最准确和最新的文献,重点关注 tau 修饰、错误折叠及其病理自组装起始之间的精确分子事件。在这些事件中,我们可以确定 tau 磷酸化、tau 杂芳基化与自组装起始之间的联系以及涉及天然多磷酸盐的可能代谢途径等方面的挑战,这些可能在 tau 自组装中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d1/9032712/c8238cc0c565/ijms-23-04192-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d1/9032712/092b4af260f8/ijms-23-04192-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d1/9032712/c8238cc0c565/ijms-23-04192-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d1/9032712/092b4af260f8/ijms-23-04192-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d1/9032712/c8238cc0c565/ijms-23-04192-g002.jpg

相似文献

1
Alzheimer's Disease and Tau Self-Assembly: In the Search of the Missing Link.阿尔茨海默病与 Tau 自组装:寻找缺失的环节。
Int J Mol Sci. 2022 Apr 10;23(8):4192. doi: 10.3390/ijms23084192.
2
Tau therapeutic strategies for the treatment of Alzheimer's disease.用于治疗阿尔茨海默病的tau蛋白治疗策略。
Curr Top Med Chem. 2006;6(6):579-95. doi: 10.2174/156802606776743057.
3
Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.参与阿尔茨海默病神经纤维变性的激酶、磷酸酶及tau位点。
Eur J Neurosci. 2007 Jan;25(1):59-68. doi: 10.1111/j.1460-9568.2006.05226.x.
4
Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.新型药物通过影响 tau 蛋白行为治疗阿尔茨海默病和 tau 相关神经退行性疾病。
Curr Alzheimer Res. 2011 Sep;8(6):678-85. doi: 10.2174/156720511796717122.
5
Tau phosphorylation and assembly.tau蛋白磷酸化与组装
Acta Neurobiol Exp (Wars). 2004;64(1):33-9. doi: 10.55782/ane-2004-1489.
6
Tau-mediated Neurodegeneration and Potential Implications in Diagnosis and Treatment of Alzheimer's Disease.tau 介导的神经退行性变及其在阿尔茨海默病诊断和治疗中的潜在意义。
Chin Med J (Engl). 2017 Dec 20;130(24):2978-2990. doi: 10.4103/0366-6999.220313.
7
In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings.体内 tau PET 成像在痴呆中的应用:发病机制、示踪剂定量及临床研究结果的系统综述。
Ageing Res Rev. 2017 Jul;36:50-63. doi: 10.1016/j.arr.2017.03.002. Epub 2017 Mar 15.
8
Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration.tau 异常过度磷酸化:部位、调节及神经原纤维变性的分子机制。
J Alzheimers Dis. 2013;33 Suppl 1:S123-39. doi: 10.3233/JAD-2012-129031.
9
Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology.tau 介导的神经退行性变:对阿尔茨海默病病理学的深入了解。
Neurochem Res. 2011 Aug;36(8):1329-35. doi: 10.1007/s11064-011-0475-5. Epub 2011 Apr 21.
10
Neurodegeneration and plasticity.神经退行性变与可塑性
Int J Dev Neurosci. 2004 Nov;22(7):507-14. doi: 10.1016/j.ijdevneu.2004.07.007.

引用本文的文献

1
Systems pharmacology identifies ajugol-mediated NF-κB/caspase-3 inhibition and isoacteoside-driven p62/mTOR-mediated autophagy as key mechanisms of Rehmanniae Radix and its processed form in Alzheimer's treatment.系统药理学确定了紫丁香苷介导的NF-κB/半胱天冬酶-3抑制以及异毛蕊花糖苷驱动的p62/雷帕霉素靶蛋白介导的自噬,作为生地黄及其炮制品在治疗阿尔茨海默病中的关键机制。
Front Pharmacol. 2025 Aug 29;16:1644847. doi: 10.3389/fphar.2025.1644847. eCollection 2025.
2
Inorganic Polyphosphate: An Emerging Regulator of Neuronal Bioenergetics and Its Implications in Neuroprotection.无机多聚磷酸盐:神经元生物能量学的新兴调节因子及其在神经保护中的意义
Biomolecules. 2025 Jul 22;15(8):1060. doi: 10.3390/biom15081060.
3

本文引用的文献

1
MAP/Microtubule Affinity Regulating Kinase 4 Inhibitory Potential of Irisin: A New Therapeutic Strategy to Combat Cancer and Alzheimer's Disease.鸢尾素抑制丝氨酸/苏氨酸蛋白激酶 MAP/Microtubule Affinity Regulating Kinase 4 的潜力:一种对抗癌症和阿尔茨海默病的新治疗策略。
Int J Mol Sci. 2021 Oct 12;22(20):10986. doi: 10.3390/ijms222010986.
2
Cryo-EM structures of tau filaments from Alzheimer's disease with PET ligand APN-1607.阿尔茨海默病 Tau 丝与 PET 配体 APN-1607 的冷冻电镜结构。
Acta Neuropathol. 2021 May;141(5):697-708. doi: 10.1007/s00401-021-02294-3. Epub 2021 Mar 16.
3
PHF-Core Tau as the Potential Initiating Event for Tau Pathology in Alzheimer's Disease.
A novel luciferase-based assay for quantifying coronavirus-induced syncytia.
一种基于荧光素酶的新型检测方法,用于定量冠状病毒诱导的合胞体。
Sci Rep. 2025 May 20;15(1):17423. doi: 10.1038/s41598-025-02037-4.
4
Synthetic CB1 Cannabinoids Promote Tunneling Nanotube Communication, Cellular Migration, and Epithelial-Mesenchymal Transition in Pancreatic PANC-1 and Colorectal SW-620 Cancer Cell Lines.合成CB1大麻素促进胰腺PANC - 1和结肠直肠SW - 620癌细胞系中的隧道纳米管通讯、细胞迁移和上皮-间质转化。
Cells. 2025 Jan 7;14(2):71. doi: 10.3390/cells14020071.
5
The Kynurenine Pathway, Aryl Hydrocarbon Receptor, and Alzheimer's Disease.犬尿氨酸途径、芳烃受体与阿尔茨海默病
Brain Sci. 2024 Sep 23;14(9):950. doi: 10.3390/brainsci14090950.
6
Drug Target to Alleviate Mitochondrial Dysfunctions in Alzheimer's Disease: Recent Advances and Therapeutic Implications.药物靶点缓解阿尔茨海默病中的线粒体功能障碍:最新进展及治疗意义。
Curr Neuropharmacol. 2024;22(12):1942-1959. doi: 10.2174/1570159X22666240426091311.
7
Exploration of the pharmacological components and therapeutic mechanisms in treatment of Alzheimer's disease with Polygonati Rhizoma and its processed product using combined analysis of metabolomics, network pharmacology, and gut microbiota.基于代谢组学、网络药理学和肠道微生物群的联合分析探索黄精及其炮制品治疗阿尔茨海默病的药理成分和作用机制
Heliyon. 2024 Jul 30;10(15):e35394. doi: 10.1016/j.heliyon.2024.e35394. eCollection 2024 Aug 15.
8
Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer's Disease.β-淀粉样蛋白和磷酸化tau蛋白是阿尔茨海默病的关键生物标志物和预测指标。
Aging Dis. 2024 Apr 24;16(2):658-682. doi: 10.14336/AD.2024.0286.
9
The Role of Neurons in Human Health and Disease.神经元在人类健康和疾病中的作用。
Int J Mol Sci. 2023 Apr 12;24(8):7107. doi: 10.3390/ijms24087107.
10
New insights toward molecular and nanotechnological approaches to antidiabetic agents for Alzheimer's disease.针对阿尔茨海默病的抗糖尿病药物的分子和纳米技术方法的新见解。
Mol Cell Biochem. 2023 Dec;478(12):2739-2762. doi: 10.1007/s11010-023-04696-1. Epub 2023 Mar 22.
PHF核心tau蛋白作为阿尔茨海默病中tau蛋白病理改变的潜在起始事件。
Front Cell Neurosci. 2020 Sep 10;14:247. doi: 10.3389/fncel.2020.00247. eCollection 2020.
4
Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions.高磷酸化 tau 聚集和细胞毒性调节剂筛选鉴定出与阿尔茨海默病和认知功能相关的处方药物。
Sci Rep. 2020 Oct 6;10(1):16551. doi: 10.1038/s41598-020-73680-2.
5
Negative feedback control of neuronal activity by microglia.小胶质细胞对神经元活动的负反馈控制。
Nature. 2020 Oct;586(7829):417-423. doi: 10.1038/s41586-020-2777-8. Epub 2020 Sep 30.
6
Role of tau protein in Alzheimer's disease: The prime pathological player.tau 蛋白在阿尔茨海默病中的作用:主要的病理元凶。
Int J Biol Macromol. 2020 Nov 15;163:1599-1617. doi: 10.1016/j.ijbiomac.2020.07.327. Epub 2020 Aug 9.
7
Inflammation: A Major Target for Compounds to Control Alzheimer's Disease.炎症:控制阿尔茨海默病的化合物的主要靶点。
J Alzheimers Dis. 2020;76(4):1199-1213. doi: 10.3233/JAD-191014.
8
MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer's Disease Therapy.MARK4 受 AChE 抑制剂(多奈哌齐和重酒石酸卡巴拉汀)抑制:对阿尔茨海默病治疗的新见解。
Biomolecules. 2020 May 20;10(5):789. doi: 10.3390/biom10050789.
9
Is AD a Stress-Related Disorder? Focus on the HPA Axis and Its Promising Therapeutic Targets.阿尔茨海默病是一种与压力相关的疾病吗?聚焦于下丘脑-垂体-肾上腺轴及其有前景的治疗靶点。
Front Aging Neurosci. 2019 Sep 27;11:269. doi: 10.3389/fnagi.2019.00269. eCollection 2019.
10
Neuroinflammation as a Common Feature of Neurodegenerative Disorders.神经炎症作为神经退行性疾病的共同特征。
Front Pharmacol. 2019 Sep 12;10:1008. doi: 10.3389/fphar.2019.01008. eCollection 2019.